Clin2
NCT06079021Worth exploringRecruiting

Study of a blood filter for sudden liver failure

Acute-On-Chronic Liver FailureAnticoagulant Adverse ReactionSarcopeniaUltrasonography

Part of Brain & nervous system, Digestive system clinical trials.

This trial tests a device called CytoSorb that filters the blood to reduce inflammation in patients with sudden worsening of chronic liver disease. It may help support organ function and recovery.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
20 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 or older and admitted to University Hospital Antwerp.
  • You have sudden liver failure (ACLF) with confusion, kidney injury, jaundice, and needing medicine to keep blood pressure up.
  • You have a known trigger for the liver worsening, like an infection or bleeding.
  • You or your family can give permission for the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06562803Recruiting
Cleaning the blood for liver failure with sepsis

This trial tests if a special blood-filtering method combined with plasma exchange can help people with severe liver failure and sepsis. It aims to reduce inflammation and improve survival.

Guangzhou, Guangdong
NCT06142968Not yet recruiting
Study of sudden liver failure in cirrhosis patients

This study looks at people with liver cirrhosis who develop a sudden, severe worsening of their liver function (called acute-on-chronic liver failure). It aims to better understand this condition and how it affects patients in the intensive care unit, which could help improve care.

NCT05146336Recruiting
CytoSorb registry for critically ill patients needing blood treatment

This registry collects information about critically ill patients who receive the CytoSorb 300 mL blood treatment. It may help doctors better understand when the treatment works best and when it should not be used.

Klagenfurt
NCT06837766Recruiting
Blood filtering for severe liver failure with organ damage

This study tests a blood-filtering system called CytoSorb in people with severe liver failure that also affects other organs. It aims to see if removing toxins from the blood can help reduce damage and improve recovery.

Ancona, Ancona
NCT07419802Recruiting
Study of a special filter for septic shock patients

This trial tests a special blood filter called Oxiris that may help remove toxins and inflammation from the blood in patients with septic shock. It aims to see if this treatment can improve outcomes for people who need kidney replacement therapy.

Riga
NCT07178366Not yet recruiting
Plasma treatment for sudden liver failure

This study tests a treatment that cleans your blood to help your liver recover if you have sudden liver failure. It may improve your chances of getting better.

Hear when a new Acute-On-Chronic Liver Failure trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.